113 related articles for article (PubMed ID: 34087455)
1. Expression of Transforming Growth Factor β1, Smad3, and Phospho-Smad3 in Somatotropinomas and Their Relationship to Tumor Behavior.
Li Z; Li J; Shan X; Gui S; Li C; Zhang Y
World Neurosurg; 2021 Sep; 153():e20-e27. PubMed ID: 34087455
[TBL] [Abstract][Full Text] [Related]
2. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.
Zhenye L; Chuzhong L; Youtu W; Xiaolei L; Lei C; Lichuan H; Hongyun W; Yonggang W; Fei W; Yazhuo Z
J Transl Med; 2014 Mar; 12():71. PubMed ID: 24636138
[TBL] [Abstract][Full Text] [Related]
3. HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells.
Nie Y; Cui D; Pan Z; Deng J; Huang Q; Wu K
Mol Vis; 2008 Sep; 14():1631-8. PubMed ID: 18776948
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
5. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
6. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
7. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
8. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
9. Validation of immunohistochemistry for somatostatin receptor subtype 2A in human somatotropinomas: comparison between quantitative real time RT-PCR and immunohistochemistry.
Wildemberg LE; Vieira Neto L; Costa DF; Nasciutti LE; Takiya CM; Alves LM; Gadelha MR
J Endocrinol Invest; 2012 Jun; 35(6):580-4. PubMed ID: 21897115
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis.
Yeh YC; Wei WC; Wang YK; Lin SC; Sung JM; Tang MJ
Am J Pathol; 2010 Oct; 177(4):1743-54. PubMed ID: 20709799
[TBL] [Abstract][Full Text] [Related]
12. Investigating dysregulation of TGF-β1/SMAD3 signaling in atopic dermatitis: a molecular and immunohistochemical analysis.
Shafi T; Rasool Wani R; Hussain S; Bhat IA; Makhdoomi R; Bashir SA; Hassan I; Shah ZA
Clin Exp Immunol; 2024 Apr; 216(2):192-199. PubMed ID: 38066678
[TBL] [Abstract][Full Text] [Related]
13. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats.
Zhu H; Gui Q; Hui X; Wang X; Jiang J; Ding L; Sun X; Wang Y; Chen H
Med Sci Monit; 2017 Jan; 23():366-376. PubMed ID: 28110342
[TBL] [Abstract][Full Text] [Related]
15. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of transforming growth factor beta1 in myofibroblast differentiation].
Liu HX; Wang SW; Zhao CH; Liu Y; Li Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):986-9. PubMed ID: 17961388
[TBL] [Abstract][Full Text] [Related]
17. Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells.
Shimizu H; Yisireyili M; Nishijima F; Niwa T
Am J Nephrol; 2013; 37(2):97-103. PubMed ID: 23363842
[TBL] [Abstract][Full Text] [Related]
18. Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.
Liu B; Zhang X; Zhang FC; Zong JB; Zhang W; Zhao Y
World J Gastroenterol; 2013 Sep; 19(35):5828-36. PubMed ID: 24124327
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid attenuates the renal interstitial fibrosis lesion in rats but not by transforming growth factor-β1/Smad3 signaling pathway.
Li ZY; Zhou TB; Qin YH; Su LN; Xu HL; Lei FY
Ren Fail; 2013; 35(2):262-7. PubMed ID: 23176567
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
Huang Z; Li S; Fan W; Ma Q
Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
